By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Herborium Group, Inc.

Herborium Group, Inc. (HBRM)

OTC Currency in USD
$0.00
$0.00
0.00%
Last Update: 3 Sept 2025, 19:40
$962.95K
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.00 - $0.00
52 Week Range

HBRM Stock Price Chart

Explore Herborium Group, Inc. interactive price chart. Choose custom timeframes to analyze HBRM price movements and trends.

HBRM Company Profile

Discover essential business fundamentals and corporate details for Herborium Group, Inc. (HBRM) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

13 Jul 1998

Employees

2.00

CEO

Agnes P. Olszewski MBA,

Description

Herborium Group, Inc., a botanical therapeutics company, develops, licenses, and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. It offers dermatology products, which include AcnEase, herbal medicinal product for enhancing conditions associated with hormonal acne and multiple symptoms of Rosacea; and AcnEase Skin Management System for the treatment of acne marks/scars. The company also provides sexual health and performance products that are non-prescriptive alternatives to selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, and surgical procedures, including hysterectomy. In addition, it offers energy restoration products, such as Lasting Energy, a herbal supplement to decrease the symptoms associated with hangovers and eliminating jet-lag; and for treating overall depletion of energy due to competitive sports, high levels of stress, and extensive sexual activities, as well as other long term or temporary physical demands. Further, the company provides Liver Activator Series for the treatment of liver damage; ProstAid, a natural product focuses on Benign Prostate Hyperplasia; and CardioVitae, a fermentation based product using a Lucidium derived cell line targeting cardio-pulmonary insufficiencies. Herborium Group, Inc. sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. The company was founded in 2000 and is headquartered in Fort Lee, New Jersey.

HBRM Financial Timeline

Browse a chronological timeline of Herborium Group, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 10 Jul 2024

Earnings released on 18 Apr 2024

Earnings released on 15 Feb 2024

Earnings released on 28 Dec 2023

Earnings released on 15 Jul 2023

Earnings released on 17 Apr 2023

Earnings released on 21 Jul 2022

Earnings released on 25 Apr 2022

HBRM Stock Performance

Access detailed HBRM performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run